Maat Pharma SA
PAR:MAAT

Watchlist Manager

Maat Pharma SA

PAR:MAAT

Watchlist

Dividends

Price: 5.2 EUR -0.38% Market Closed

Market Cap: 83.8m EUR

Have any thoughts about
Maat Pharma SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 5.2 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MAAT Alert

Maat Pharma SA

5.2

-0.02 (-0.38%)

52 Week Range	4.86 9.08
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Maat Pharma SA

What unique competitive advantages
does Maat Pharma SA hold over its rivals?

What risks and challenges
does Maat Pharma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Maat Pharma SA.

What unique competitive advantages
does Maat Pharma SA hold over its rivals?

What risks and challenges
does Maat Pharma SA face in the near future?

Has there been any significant insider trading activity
in Maat Pharma SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Maat Pharma SA.

Provide P/S
for Maat Pharma SA.

Provide P/E
for Maat Pharma SA.

Provide P/OCF
for Maat Pharma SA.

Provide P/FCFE
for Maat Pharma SA.

Provide P/B
for Maat Pharma SA.

Provide EV/S
for Maat Pharma SA.

Provide EV/GP
for Maat Pharma SA.

Provide EV/EBITDA
for Maat Pharma SA.

Provide EV/EBIT
for Maat Pharma SA.

Provide EV/OCF
for Maat Pharma SA.

Provide EV/FCFF
for Maat Pharma SA.

Provide EV/IC
for Maat Pharma SA.

Show me price targets
for Maat Pharma SA made by professional analysts.

What are the Revenue projections
for Maat Pharma SA?

How accurate were the past Revenue estimates
for Maat Pharma SA?

What are the Net Income projections
for Maat Pharma SA?

How accurate were the past Net Income estimates
for Maat Pharma SA?

What are the EPS projections
for Maat Pharma SA?

How accurate were the past EPS estimates
for Maat Pharma SA?

What are the EBIT projections
for Maat Pharma SA?

How accurate were the past EBIT estimates
for Maat Pharma SA?

Compare the revenue forecasts
for Maat Pharma SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Maat Pharma SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Maat Pharma SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Maat Pharma SA compared to its peers.

Compare the P/E ratios
of Maat Pharma SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Maat Pharma SA with its peers.

Analyze the financial leverage
of Maat Pharma SA compared to its main competitors.

Show all profitability ratios
for Maat Pharma SA.

Provide ROE
for Maat Pharma SA.

Provide ROA
for Maat Pharma SA.

Provide ROIC
for Maat Pharma SA.

Provide ROCE
for Maat Pharma SA.

Provide Gross Margin
for Maat Pharma SA.

Provide Operating Margin
for Maat Pharma SA.

Provide Net Margin
for Maat Pharma SA.

Provide FCF Margin
for Maat Pharma SA.

Show all solvency ratios
for Maat Pharma SA.

Provide D/E Ratio
for Maat Pharma SA.

Provide D/A Ratio
for Maat Pharma SA.

Provide Interest Coverage Ratio
for Maat Pharma SA.

Provide Altman Z-Score Ratio
for Maat Pharma SA.

Provide Quick Ratio
for Maat Pharma SA.

Provide Current Ratio
for Maat Pharma SA.

Provide Cash Ratio
for Maat Pharma SA.

What is the historical Revenue growth
over the last 5 years for Maat Pharma SA?

What is the historical Net Income growth
over the last 5 years for Maat Pharma SA?

What is the current Free Cash Flow
of Maat Pharma SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Maat Pharma SA.

Section:

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 18.02 EUR with a low forecast of 15.66 EUR and a high forecast of 22.05 EUR.

MAAT Average Forecast

Wall Street Target

18.02 EUR

247% Upside

MAAT Highest Forecast

Wall Street Target

22.05 EUR

324% Upside

Lowest

Price Target

15.66 EUR

201% Upside

Average

Price Target

18.02 EUR

247% Upside

Highest

Price Target

22.05 EUR

324% Upside

Maat Pharma SA Competitors:
Price Targets

206650

EuBiologics Co Ltd

28% Upside

ALNY

Alnylam Pharmaceuticals Inc

6% Upside

4584

Kidswell Bio Corporation

14% Upside

STTK

Shattuck Labs Inc

162% Upside

206650

EuBiologics Co Ltd

28% Upside

ALNY

Alnylam Pharmaceuticals Inc

6% Upside

4584

Kidswell Bio Corporation

14% Upside

STTK

Shattuck Labs Inc

162% Upside

300685

Amoy Diagnostics Co Ltd

46% Upside

STOK

Stoke Therapeutics Inc

97% Upside

87S

Roivant Sciences Ltd

57% Upside

2487

Cutia Therapeutics

12% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

N/A

Past Growth

166%

Estimated Growth

Estimates Accuracy

-25%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-35%

Average Miss

What are analyst estimates?

What is MAAT's stock price target?

Price Target
18.02 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 18.02 EUR with a low forecast of 15.66 EUR and a high forecast of 22.05 EUR.

What is Maat Pharma SA's Revenue forecast?

Projected CAGR
166%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 166%.

	Franklin Covey Co NYSE:FC	22.27 USD 0.04%
	Mohawk Industries Inc NYSE:MHK	102.58 USD 3.06%
	Ardmore Shipping Corp NYSE:ASC	9.86 USD -2.67%
	ASGN Inc NYSE:ASGN	48.55 USD -0.06%
	Skyworks Solutions Inc NASDAQ:SWKS	72.32 USD 0.26%
	Weatherford International PLC NASDAQ:WFRD	47.23 USD -7.46%

	Johnson & Johnson NYSE:JNJ	150.8 USD 0.67%
	Bank of America Corp NYSE:BAC	46.13 USD 1.38%
	Mastercard Inc NYSE:MA	541.28 USD 1.56%
	Salesforce Inc NYSE:CRM	263.41 USD 1.07%
	Abbvie Inc NYSE:ABBV	183.76 USD -0.83%
	Home Depot Inc NYSE:HD	356.3 USD 1.91%

	Arista Networks Inc NYSE:ANET	91.98 USD 6.64%
	Deckers Outdoor Corp NYSE:DECK	100.44 USD -1.23%
	Visa Inc NYSE:V	342.79 USD 1.25%
	Texas Pacific Land Corp NYSE:TPL	1 042.88 USD -3.81%
	KLA Corp NASDAQ:KLAC	849.81 USD -0.02%
	Manhattan Associates Inc NASDAQ:MANH	192.18 USD 3.16%

	Salesforce Inc NYSE:CRM	263.41 USD 1.07%
	Accenture PLC NYSE:ACN	295 USD 3.37%
	ServiceNow Inc NYSE:NOW	980.4 USD 0.93%
	Spotify Technology SA NYSE:SPOT	730.15 USD 3.21%
	EOG Resources Inc NYSE:EOG	121.99 USD -2.66%
	Monster Beverage Corp NASDAQ:MNST	63.21 USD 0.19%

Maat Pharma SA
PAR:MAAT

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

See Also

What is MAAT's stock price target?

Price Target
18.02 EUR

What is Maat Pharma SA's Revenue forecast?

Projected CAGR
166%

Company

Help

Tools

Stocks

Maat Pharma SA PAR:MAAT

Wall Street Price Targets

MAAT Price Targets Summary Maat Pharma SA

Revenue Forecast

Revenue Estimate Maat Pharma SA

Operating Income Forecast

Operating Income Estimate Maat Pharma SA

Net Income Forecast

Net Income Estimate Maat Pharma SA

See Also

What is MAAT's stock price target? Price Target 18.02 EUR

What is Maat Pharma SA's Revenue forecast? Projected CAGR 166%

Company

Help

Tools

Stocks

Maat Pharma SA
PAR:MAAT

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

What is MAAT's stock price target?

Price Target
18.02 EUR

What is Maat Pharma SA's Revenue forecast?

Projected CAGR
166%